RARß Agonist Drug (C286) Demonstrates Efficacy in a Pre-clinical Neuropathic Pain Model Restoring Multiple Pathways via DNA Repair Mechanisms. (2019)
Attributed to:
A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.isci.2019.09.020
PubMed Identifier: 31655065
Publication URI: http://europepmc.org/abstract/MED/31655065
Type: Journal Article/Review
Volume: 20
Parent Publication: iScience
ISSN: 2589-0042